Grace Therapeutics, Inc. (GRCE) Total liabilities 2022–2023
Grace Therapeutics, Inc. (GRCE) total liabilities at each fiscal year-end, per SEC filings.
$20.4MFY2023 · since FY2022: $6.8M → $20.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $20.4M | +199.4% |
| FY2022 | $6.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More GRCE financial trends
GRCE RevenueGRCE Net incomeGRCE Net marginGRCE Gross profitGRCE Gross marginGRCE Operating incomeGRCE Operating marginGRCE Operating cash flowGRCE Free cash flowGRCE Capital expendituresGRCE Return on equityGRCE Stock buybacksGRCE Dividends paidGRCE Total assetsGRCE Shareholders’ equityGRCE overview →